Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4J452 | — |
42 years old patient received only the sterile saline diluent part of Hiberix; 42 years old patient received only the sterile saline diluent part of Hiberix; 42 years old patient received only the sterile saline diluent part of Hiberix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 42-year-old female patient who received Hib (Hiberix) (batch number 4J452, expiry date 15-MAR-2026) for prophylaxis. On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced inappropriate age at vaccine administration (Verbatim: 42 years old patient received only the sterile saline diluent part of Hiberix), inappropriate preparation of medication (Verbatim: 42 years old patient received only the sterile saline diluent part of Hiberix) and inappropriate dose of vaccine administered (Verbatim: 42 years old patient received only the sterile saline diluent part of Hiberix). The outcome of the inappropriate age at vaccine administration, inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 10-MAR-2025 Reporter stated that they administered only the sterile saline diluent part of Hiberix to a 42 years old female patient which led to inappropriate age at vaccination , inappropriate preparation of medication and inappropriate dose of vaccine administered. Also asked when can they revaccinate the patient.